Ten-Year Persistence of Antibody to Hepatitis B Surface Antigen in Healthcare Workers Vaccinated Against Hepatitis B Virus, and Response to Booster Vaccination

Infection Control and Hospital Epidemiology

Volumn 24, Issue 10, 2003, Pages 773-776

  Durlach, Ricardo ^a,b   Laugas, Stella ^a   Freuler, Cristina B ^a   Rodriguez, Viviana E ^a   Costa, Marta ^a  

^a HOSPITAL ALEMÁN   (Argentina)

^b NONE   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; RECOMBINANT HEPATITIS B VACCINE;

ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; FEMALE; HEALTH CARE PERSONNEL; HEPATITIS B; HUMAN; IMMUNOLOGICAL MEMORY; MALE; MICROPARTICLE ENZYME IMMUNOASSAY; OCCUPATIONAL EXPOSURE; REVACCINATION; VACCINATION; VIRUS HEPATITIS; VIRUS INFECTION;

ADULT; ANTIBODIES, VIRAL; ARGENTINA; FEMALE; HEALTH PERSONNEL; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION, SECONDARY; MALE; MIDDLE AGED;

EID: 0142153058     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/502132     Document Type: Article

References (17)

1. Center for Disease Control. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1991;40(RR-13):1-19.
2. Hadler SC, Margolis HS. Viral hepatitis. In: Evans AS, ed. Viral Infections of Humans, 3rd ed. New York: Plenum; 1991;351-391.
3. Wu JS, Hwang LY, Goodman KS, Beasley RP. Hepatitis B vaccination in high-risk infants: 10 years follow-up. J Infect Dis 1999;179:1319-1325.
4. European Consensus Group on Hepatitis B Immunity. Are booster immunizations needed for lifelong hepatitis B immunity? Lancet 2000;355:561-565.
5. Jilg W, Schmidt M, Deinhart F. Four-year experience with a recombinant hepatitis B vaccine. Infection 1989;17:70-76.
6. Barash C, Conn MI, Di Marino AJ, Marzano J, Allen M. Serologic hepatitis B immunity in vaccinated health care workers. Arch Intern Med 1999;159:1481-1483.
7. Van Herck K, Van Damme P, Thoelen S, Meheus A. Long-term persistence of anti-HBs after vaccination with a recombinant DNA yeast-derived hepatitis B vaccine: 8 years results. Vaccine 1998;16:1933-1935.
8. Jilg W, Schmidt M, Dienhardt F. Persistence of specific antibodies after hepatitis B vaccination. J Hepatol 1988;6:201-207.
9. AIDS/TB Committee of the Society for Healthcare Epidemiology of America. Management of healthcare workers infected with hepatitis B virus, hepatitis C virus, human immunodeficiency virus or other bloodborne pathogens. Infect Control Hosp Epidemiol 1997;18:349-363.
10. Catterall AP, Murray-Lyon MI. Strategies for hepatitis B immunization. Gut 1992;33:576-579.
11. Koziol DE, Henderson DK. Nosocomial viral hepatitis in health care workers. In: Mayhall CG, ed. Hospital Epidemiology and Infection Control, 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 1999:1057-1073.
12. Ni YH, Chang MH, Huang LM, et al. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med 2001;135:796-800.
13. McMahon BJ, Holck P, Bulkow L, Snowball M. Serologic and clinical outcomes of 1536 Alaska natives chronically infected with hepatitis B virus. Ann Intern Med 2001;135:759-768.
14. Da Villa G, Peluso F, Picciotto L, Bencivenga M, Elia S, Pelliccia MG. Persistence of anti-HBs in children vaccinated against viral hepatitis B in the first year of life: follow-up at 5 and 10 years. Vaccine 1996;14:1503-1505.
15. Laugas S, Freuler CB, Rodriguez VE, Durlach RA. Antibody level of hepatitis B after 10 years vaccination. Presented at the 4th Decennial International Conference on Nosocomial and Healthcare Associated Infections; March 5-9, 2000; Atlanta, GA.
16. Wismans PJ, van Hattum J, Mudde GC, Endeman HJ, Poel J, de Gast GC. Is booster injection with hepatitis B vaccine necessary in healthy responders? A study of the immune response. J Hepatol 1989;8:236-240.
17. Wainwright RB, Bulkow LR, Parkinson AJ, Zanis C, McMahon BJ. Protection provided by hepatitis B vaccine in a Yupik Eskimo population: results of a 10-year study. J Infect Dis 1997;175:674-677.